Stitch Fix Reports Q2 Results, Settles Class Action, and Key Executives Adopt Large 10b5-1 Plans
SFIX sits 25% above its 52-week low of $2.6 on elevated volume (2.0× avg).
Summary
Stitch Fix reported Q2 fiscal 2026 results with revenue growth and reduced net loss, but active client count declined. The company settled a $32.0 million class action lawsuit and extended its credit facility. Notably, several key executives adopted significant 10b5-1 selling plans.
Key Events · Earnings and Guidance · SFIX
-
Q2 Fiscal 2026 Financial Performance
Net revenue increased 9.4% year-over-year to $341.3 million for the three months ended January 31, 2026. Net loss from continuing operations improved to $(2.7) million from $(6.6) million in the prior year. Adjusted EBITDA was positive at $15.9 million, consistent with the prior year.
-
Continued Decline in Active Clients
Active clients decreased by 3.5% year-over-year to 2,288,000 as of January 31, 2026, indicating ongoing challenges in client acquisition and retention, despite an increase in net revenue per active client to $577.
-
Significant Class Action Lawsuit Settlement
The company agreed to pay $32.0 million to settle a federal securities class action lawsuit, with the amount expected to be covered by insurance policies. Court approval for the settlement is pending.
-
Credit Facility Maturity Extended
The maturity date of the $50.0 million revolving credit facility was extended from December 4, 2026, to December 11, 2028, enhancing the company's liquidity runway. As of January 31, 2026, the company had $33.1 million in excess borrowing availability and no outstanding borrowings.
Analysis · SFIX · Trade & Services
Stitch Fix's Q2 fiscal 2026 results show mixed performance with revenue growth and improved profitability, but a continued decline in active clients. The company reported a significant $32.0 million settlement for a class action lawsuit, though it is covered by insurance. Furthermore, the extension of the credit facility provides improved liquidity. A notable development is the adoption of substantial 10b5-1 selling plans by the CEO, CFO, CLO, and a Director, signaling potential future share dispositions by key executives. These planned sales represent a significant portion of the company's outstanding shares, which could be perceived negatively by the market.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.4% of the 1070 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SFIX was trading at $3.25 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $442.9M. The 52-week trading range was $2.60 to $5.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.